1-6 of 6
Finn Petersen, MD
Close
Sort by
Journal Articles

Total Body Irradiation (TBI) Dose Escalation Decreases Risk of Progression and Graft Rejection after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Myelodysplastic Syndrome (MDS) or Myeloproliferative Neoplasms (MPN)

Federico Monaco, MD, Bart L. Scott, MD, Thomas Chauncey, MD PhD, Finn Petersen, MD, Barry E. Storer, PhD, Frederic Baron, Mary E. Flowers, MD, H. Joachim Deeg, MD, Rainer F. Storb, MD, David G. Maloney, MD PhD, Brenda M. Sandmaier, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 908.
https://doi.org/10.1182/blood.V130.Suppl_1.908.908
Published: 2017
Journal Articles

A Prospective Multicenter Study of Nonmyeloablative Conditioning with TBI or Fludarabine/TBI for HLA-Matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies with Post Grafting Immunosuppression with Tacrolimus and Mycophenolate Mofetil: 10-Year Experience

Huiying Qiu, MD, Brenda M. Sandmaier, MD, Barry E. Storer, PhD, Thomas Chauncey, MD PhD, Finn Petersen, MD, Michael A. Pulsipher, Benedetto Bruno, MD, Mary Flowers, MD, Marco Mielcarek, MD, Rainer Storb, MD, David G Maloney, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1949.
https://doi.org/10.1182/blood.V126.23.1949.1949
Published: 2015
Journal Articles

A Randomized 3-Arm Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute Graft-Versus-Host Disease (GVHD) After Unrelated Donor Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Conditioning for Patients with Hematologic Malignancies: A Multi-Center Trial.

Brenda M. Sandmaier, MD, Michael Maris, MD, Barry Storer, PhD, Lars Vindelov, MD, Amelia Langston, MD, James C. Wade, MD, MPH, Wolfgang A. Bethge, MD, Michael Pulsipher, MD, Thoralf Lange, MD, Thomas Chauncey, MD, Finn Petersen, MD, Kai Hübel, MD, Ann Woolfrey, MD, Mary E.D. Flowers, MD, David G. Maloney, MD, PhD, Rainer F. Storb, MD
Journal: Blood
Blood (2009) 114 (22): 348.
https://doi.org/10.1182/blood.V114.22.348.348
Published: 2009
Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Patients (pts) Aged ≥60 Years.

Mohamed L. Sorror, MD, MSc, Barry Storer, PhD, Brenda M. Sandmaier, MD, David G. Maloney, MD, PhD, Georg Franke, MD, Judith Shizuru, MD, PhD, Thomas Chauncey, MD, Edward Agura, MD, Richard T. Maziarz, MD, Firoozeh Sahebi, MD, Amelia A Langston, MD, James C. Wade, MD, MPH, Michael Maris, MD, Benedetto Bruno, MD, Andrew M. Yeager, MD, Michael Pulsipher, MD, Finn Petersen, MD, Wolfgang A. Bethge, MD, Peter A. McSweeney, MD, Dietger Niederwieser, MD, Karl G. Blume, MD, Rainer F. Storb, MD
Journal: Blood
Blood (2008) 112 (11): 2162.
https://doi.org/10.1182/blood.V112.11.2162.2162
Published: 2008
Journal Articles

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients with De Novo and Secondary Acute Myeloid Leukemia

Boglarka Gyurkocza, MD, Rainer F. Storb, MD, Barry Storer, PhD, Thomas Chauncey, MD, Dietger Niederwieser, MD, Judith Shizuru, MD, PhD, Amelia Langston, MD, Michael Pulsipher, MD, Christopher Bredeson, MD, Richard T. Maziarz, MD, Benedetto Bruno, Finn Petersen, MD, Michael Maris, MD, Edward Agura, MD, Andrew M. Yeager, MD, Wolfgang A. Bethge, MD, Firoozeh Sahebi, Lars Vindelov, MD, Peter A. McSweeney, MD, Frederick R. Appelbaum, MD, David G. Maloney, MD, PhD, Brenda M. Sandmaier
Journal: Blood
Blood (2008) 112 (11): 149.
https://doi.org/10.1182/blood.V112.11.149.149
Published: 2008
Journal Articles

Pulmonary Changes in Myeloma Patients Following High Dose Melphalan.

Clyde Ford, MD, Robert E. Jensen, PhD, Julie Asch, MD, James E. Pearl, MD, Robert O. Crapo, MD, Finn Petersen, MD
Journal: Blood
Blood (2006) 108 (11): 2973.
https://doi.org/10.1182/blood.V108.11.2973.2973
Published: 2006